Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
4(29%)
Results Posted
80%(4 trials)

Phase Distribution

Ph phase_1
1
7%
Ph not_applicable
10
71%
Ph phase_2
1
7%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
N/ANon-phased studies
10(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

4

trials recruiting

Total Trials

14

all time

Status Distribution
Active(7)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Recruiting3
Not yet recruiting3
Active, not recruiting1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
4
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (8.3%)
Phase 21 (8.3%)
N/A10 (83.3%)

Trials by Status

active_not_recruiting17%
recruiting321%
completed536%
withdrawn17%
unknown17%
not_yet_recruiting321%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DEVICE
Total Trials
14